Hans A. Messner
#146,608
Most Influential Person Now
Hans A. Messner's AcademicInfluence.com Rankings
Hans A. Messnerphilosophy Degrees
Philosophy
#7922
World Rank
#11205
Historical Rank
Logic
#4956
World Rank
#6301
Historical Rank
Hans A. Messnerbiology Degrees
Biology
#10677
World Rank
#14028
Historical Rank
Molecular Biology
#1574
World Rank
#1602
Historical Rank
Download Badge
Philosophy Biology
Hans A. Messner's Degrees
- PhD Molecular Biology Stanford University
- Doctorate Medicine Stanford University
Why Is Hans A. Messner Influential?
(Suggest an Edit or Addition)Hans A. Messner's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Lineage infidelity in acute leukemia. (1983) (400)
- Granuloerythropoietic colonies in human bone marrow, peripheral blood, and cord blood (1978) (352)
- A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. (2002) (316)
- Identification of megakaryocytes, macrophages, and eosinophils in colonies of human bone marrow containing neurtophilic granulocytes and erythroblasts (1979) (276)
- Interacting cell populations affecting granulopoietic colony formation by normal and leukemic human marrow cells. (1973) (276)
- Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. (1996) (202)
- The growth of large megakaryocyte colonies from human bone marrow (1982) (199)
- Identification of megakaryocytes, macrophages, and eosinophils in colonies of human bone marrow containing neurtophilic granulocytes and erythroblasts. (1979) (196)
- Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents. (1987) (194)
- Heterogeneity of human peripheral blood eosinophil-type colonies: evidence for a common basophil-eosinophil progenitor. (1985) (190)
- Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia (2009) (181)
- A possible autocrine role for interleukin-6 in two lymphoma cell lines. (1989) (173)
- Quality of life following bone marrow transplantation: a comparison of patient reports with population norms (1997) (165)
- Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation. (2002) (152)
- The presence of clonogenic cells in high-grade malignant lymphoma: a prognostic factor. (1987) (138)
- Treatment of adults with BCR‐ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen (2009) (134)
- A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation. (1998) (132)
- Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells. (2005) (129)
- Small‐Airways Disease in Recipients of Allogeneic Bone Marrow Transplants: AN ANALYSIS OF 11 CASES AND A REVIEW OF THE LITERATURE (1987) (121)
- Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance. (2007) (118)
- A systematic review of transfusion-associated graft-versus-host disease. (2015) (117)
- Secondary malignancies after bone marrow transplantation in adults. (1994) (111)
- Treatment outcomes following leukemic transformation in Philadelphia-negative myeloproliferative neoplasms. (2013) (111)
- The contribution of blast cell properties to outcome variation in acute myeloblastic leukemia (AML). (1982) (110)
- The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin (2005) (110)
- Complications associated with Ommaya reservoirs in patients with cancer. The Princess Margaret Hospital experience and a review of the literature. (1990) (104)
- Growth of human hemopoietic colonies in response to recombinant gibbon interleukin 3: comparison with human recombinant granulocyte and granulocyte-macrophage colony-stimulating factor. (1987) (104)
- Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project. (2005) (98)
- Control of antibody-mediated pure red-cell aplasia by plasmapheresis. (1981) (98)
- Elevated serum cytokines are associated with cytomegalovirus infection and disease in bone marrow transplant recipients. (1999) (92)
- Surface antigenic profile and globin phenotype of two new human erythroleukemia lines: characterization and interpretations. (1988) (90)
- Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells. (1987) (87)
- The structure of the T cell gamma chain gene in lymphoproliferative disorders and lymphoma cell lines. (1986) (87)
- Cutaneous and mucosal neoplasms in bone marrow transplant recipients (1990) (86)
- Role of interleukin-6 in the proliferation of human multiple myeloma cell lines OCI-My 1 to 7 established from patients with advanced stage of the disease. (1991) (86)
- Identification of T lymphocytes in human mixed hemopoietic colonies. (1981) (85)
- Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation (2004) (85)
- Effect of noncompetitive proteasome inhibition on bortezomib resistance. (2010) (84)
- Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation (2005) (84)
- Stem cell transplantation for myelofibrosis: a report from two Canadian centers (2003) (82)
- Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: recommendations for minimization of risk. (2004) (79)
- Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease (2005) (77)
- A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients. (2007) (77)
- Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venoocclusive disease of the liver. (2002) (74)
- Proliferative state of human pluripotent hemopoietic progenitors (CFU-GEMM) in normal individuals and under regenerative conditions after bone marrow transplantation. (1979) (74)
- Vascular Events Associated with Alpha Interferon Therapy (2003) (71)
- Equally interchangeable? - How sex and gender affect transplantation. (2019) (70)
- Cytotoxicity of adriamycin and daunorubicin for normal and leukemia progenitor cells of man. (1979) (70)
- Characterization of human megakaryocytic colony formation in human plasma (1985) (69)
- Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS) (2014) (69)
- Granuloerythropoietic colonies in human bone marrow, peripheral blood, and cord blood. (1978) (68)
- Brief report: diagnosis of Whipple's disease by molecular analysis of peripheral blood. (1994) (67)
- A colony assay for blast cell progenitors in non-B non-T (common) acute lymphoblastic leukemia. (1981) (67)
- Nonmyeloablative stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia in patients 60 years or older. (2005) (66)
- Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogeneic bone marrow transplantation (1998) (63)
- Intraoral pyogenic granuloma after allogeneic bone marrow transplant. Report of three cases. (1994) (62)
- Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared to fresh allografts. (2007) (62)
- Pulmonary function abnormalities after allogeneic marrow transplantation: a systematic review and assessment of an existing predictive instrument (2002) (62)
- Aerosolized pentamidine prophylaxis for Pneumocystis carinii pneumonia after allogeneic marrow transplantation (2002) (61)
- Aerosolized pentamidine prophylaxis for Pneumocystis carinii pneumonia after allogeneic marrow transplantation (2002) (61)
- Molecular cytogenetic characterization of non‐Hodgkin lymphoma cell lines (2002) (58)
- An evaluation of the donor experience in the canadian multicenter randomized trial of bone marrow versus peripheral blood allografting. (2004) (58)
- Idiopathic Small Airways Pathology in Patients with Graft-versus-Host Disease Following Allogeneic Bone Marrow Transplantation (1987) (58)
- Abnormal thyroid stimulating hormone (TSH) levels in adults following allogeneic bone marrow transplants (1997) (55)
- Clonogenic hemopoietic precursors in bone marrow transplantation. (1987) (55)
- Bone marrow mobilized with granulocyte colony-stimulating factor in related allogeneic transplant recipients: a study of 29 patients. (2000) (54)
- Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies (2018) (54)
- The risk of polyomavirus BK-associated hemorrhagic cystitis after allogeneic hematopoietic SCT is associated with myeloablative conditioning, CMV viremia and severe acute GVHD (2014) (53)
- Human marrow cells forming colonies in culture: analysis by velocity sedimentation and suspension culture. (1972) (52)
- Autoantibody analysis of patients with graft versus host disease. (1987) (52)
- Contributions of host- and disease-related attributes to the outcome of patients with acute myelogenous leukemia. (1984) (51)
- Self-concept as a "BMT patient", illness intrusiveness, and engulfment in allogeneic bone marrow transplant recipients. (2003) (51)
- Cyproheptadine displays preclinical activity in myeloma and leukemia. (2008) (50)
- The Heritable Nature of Clonal Characteristics in Acute Myeloblastic Leukemia (1981) (50)
- Expansion and Characterization of Human Melanoma Tumor-Infiltrating Lymphocytes (TILs) (2010) (50)
- A retrospective comparison of conventional intensity conditioning and reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in myelofibrosis (2009) (50)
- Early hematopoietic reconstitution after clinical stem cell transplantation: evidence for stochastic stem cell behavior and limited acceleration in telomere loss. (2002) (50)
- Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-alpha. (1999) (49)
- The role of allogeneic bone marrow transplantation in adult patients below the age of 55 years with acute lymphoblastic leukemia in first complete remission: a donor vs no donor comparison (2004) (48)
- p53 mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's lymphoma cell lines. (1995) (48)
- Recommendations on haematological criteria for the diagnosis of epoetin‐induced pure red cell aplasia (2004) (47)
- High-dose cytosine arabinoside in the treatment of acute myelogenous leukemia: contributions to outcome of clinical and laboratory attributes. (1987) (45)
- Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low‐dose acyclovir prophylaxis and pre‐transplant diagnosis of lymphoproliferative disorders (2008) (45)
- Interferon alfa-2b in the treatment of chronic granulocytic leukemia. (1986) (44)
- Illness intrusiveness among survivors of autologous blood and marrow transplantation (2001) (44)
- Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate. (1991) (43)
- Self-renewal capacity of leukemic blast progenitor cells. (1981) (42)
- Human hematopoiesis in SCID mice implanted with human adult cancellous bone. (1996) (42)
- Genetic variants in the candidate genes of the apoptosis pathway and susceptibility to chronic myeloid leukemia. (2008) (41)
- Colony growth and self renewal of plasma cell precursors in multiple myeloma. (1985) (39)
- Subdural Hematomas during CML Therapy with Imatinib Mesylate (2004) (38)
- Acute lymphoblastic leukemia possible origin from a mediastinal germ cell tumor (1984) (37)
- Increased IFN-gamma synthesis by T cells from patients on imatinib therapy for chronic myeloid leukemia. (2002) (36)
- Clonal origin of human basophil/mast cells from circulating multipotent hemopoietic progenitors. (1985) (35)
- Long-term survival after blood and marrow transplantation: comparison with an age- and gender-matched normative population. (2006) (35)
- No significance of derivative chromosome 9 deletion on the clearance kinetics of BCR/ABL fusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemia (2008) (34)
- Nocturnal hemodialysis improves erythropoietin responsiveness and growth of hematopoietic stem cells. (2009) (34)
- Analysis of interacting cell populations in cultures of marrow from patients with neutropenia. (1974) (34)
- Incidence and risk factors for early hepatotoxicity and its impact on survival in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation. (2012) (33)
- Cyclosporine as possible prophylaxis for obstructive airways disease after allogeneic bone marrow transplantation. (1993) (33)
- Density distributions of marrow cells from mouse and man. (1972) (33)
- Fetal hemoglobin in mixed hemopoietic colonies (CFU-GEMM), erythroid bursts (BFU-E) and erythroid colonies (CFU-E): assessment by radioimmune assay and immunofluorescence. (1979) (33)
- Single-cell immunofluorescence assay for terminal transferase: Human leukaemic and non-leukaemic cells (1980) (33)
- T-cell large granular lymphocytic leukemia of donor origin occurring after allogeneic bone marrow transplantation for B-cell lymphoproliferative disorders. (2005) (32)
- Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival. (2014) (32)
- A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis (2015) (32)
- A prospective study comparing the outcomes and health-related quality of life in adult patients with myeloid malignancies undergoing allogeneic transplantation using myeloablative or reduced-intensity conditioning. (2012) (31)
- Patient age, remission status and HCT-CI in a combined score are prognostic for patients with AML undergoing allogeneic hematopoietic cell transplantation in CR1 and CR2 (2015) (31)
- Properties of human pluripotent hemopoietic progenitors. (1980) (30)
- Treatment of adults with severe aplastic anemia: primary therapy with antithymocyte globulin (ATG) and rescue of ATG failures with bone marrow transplantation. (1992) (30)
- Outcomes of older patients (≥60 years) with acquired aplastic anaemia treated with immunosuppressive therapy (2008) (29)
- Alterations of p53 and c-myc in the clonal evolution of malignant lymphoma. (1994) (29)
- Busulfan and cyclophosphamide as a preparative regimen for allogeneic blood and marrow transplantation in patients with non-Hodgkin's lymphoma (2003) (29)
- Efficacy of Cidofovir in Treatment of BK Virus-Induced Hemorrhagic Cystitis in Allogeneic Hematopoietic Cell Transplant Recipients. (2018) (29)
- Origin of leukemic relapse after bone marrow transplantation detected by restriction fragment length polymorphism. (1985) (29)
- Culture studies of human pluripotent hemopoietic progenitors (1980) (29)
- Graft-versus-host disease following marrow transplantation for aplastic anemia: different impact of two GVHD prevention strategies (2008) (29)
- Allogeneic hematopoietic cell transplantation for myelofibrosis using fludarabine-, intravenous busulfan- and low-dose TBI-based conditioning (2014) (28)
- Replicative stress after allogeneic bone marrow transplantation: changes in cycling of CD34+CD90+ and CD34+CD90- hematopoietic progenitors. (2001) (28)
- Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years) (2007) (28)
- Impact of intensity of conditioning therapy in patients aged 40–60 years with AML/myelodysplastic syndrome undergoing allogeneic transplantation (2011) (28)
- Comparable outcomes post allogeneic hematopoietic cell transplant for patients with de novo or secondary acute myeloid leukemia in first remission (2015) (28)
- Production of colony-stimulating factor(s) for granulocyte-macrophage and multipotential (granulocyte/erythroid/megakaryocyte/macrophage) hematopoietic progenitor cells (CFU-GEMM) by clonal lines of human IL-2-dependent T-lymphocytes. (1984) (28)
- Production of growth factors by malignant lymphoma cell lines. (1989) (27)
- A randomised trial comparing cytomegalovirus antigenemia assay vs screening bronchoscopy for the early detection and prevention of disease in allogeneic bone marrow and peripheral blood stem cell transplant recipients (2001) (26)
- Characterization of reticulofibroblastoid colonies (CFU‐RF) derived from bone marrow and long‐term marrow culture monolayers (1986) (26)
- Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantation (2016) (26)
- Bone marrow transplantation for leukemia and aplastic anemia: management of ABO incompatibility. (1982) (26)
- Clinical efficacy of prophylactic strategy of long‐term low‐dose acyclovir for Varicella‐Zoster virus infection after allogeneic peripheral blood stem cell transplantation * (2008) (25)
- Magnetic resonance imaging for monitoring relapse of acute myeloid leukemia. (1988) (25)
- Bone marrow aspirates as part of routine donor assessment for allogeneic blood and marrow transplantation can reveal presence of occult hematological malignancies in otherwise asymptomatic individuals (2004) (25)
- Peripheral blood eosinophilia has a favorable prognostic impact on transplant outcomes after allogeneic peripheral blood stem cell transplantation. (2009) (25)
- Biology of acute myeloid leukaemia. (1986) (24)
- Comparison of outcomes and prognostic factors for two groups of patients with acute myeloblastic leukemia. (1979) (24)
- Peripheral blood blast cell progenitors in human preleukemia. (1982) (24)
- Pharmacist's Role in Improving Medication Safety for Patients in an Allogeneic Hematopoietic Cell Transplant Ambulatory Clinic. (2013) (24)
- Duration of first remission, hematopoietic cell transplantation-specific comorbidity index and patient age predict survival of patients with AML transplanted in second CR (2013) (24)
- Hemopoietic colony growth-promoting activities in the plasma of bone marrow transplant recipients. (1988) (23)
- Treatment of Philadelphia chromosome‐positive acute lymphoblastic leukaemia with imatinib combined with a paediatric‐based protocol (2012) (23)
- Anticonvulsant-induced marrow suppression and immune thrombocytopenia. (1988) (23)
- Differential sensitivity of human myeloma cell lines and normal bone marrow colony forming cells to a recombinant diphtheria toxin‐interleukin 6 fusion protein (1993) (23)
- Relationship between premortem and postmortem diagnosis in critically ill bone marrow transplantation patients. (2002) (23)
- Large granular lymphocytosis and its impact on long-term clinical outcomes following allo-SCT (2013) (23)
- Molecularly cloned and expressed murine T-cell gene product is biologically similar to interleukin-3. (1985) (23)
- Effect of cytomegalovirus infection on 1-year mortality rates among recipients of allogeneic bone marrow transplants. (1998) (23)
- Multiple Single-Nucleotide Polymorphism–Based Risk Model for Clinical Outcomes After Allogeneic Stem-Cell Transplantation, Especially for Acute Graft-Versus-Host Disease (2012) (22)
- Experience with Ommaya Reservoir in 120 Consecutive Patients with Meningeal Malignancy (1990) (22)
- Pluripotent hemopoietic progenitors (CFU-GEMM) in polycythemia vera: analysis of erythropoietin requirement and proliferative activity. (1981) (22)
- Cytomegalovirus pneumonia in allogeneic bone marrow transplantation. An immunopathologic process? (1990) (21)
- Reverse Transcriptase Activity: Increase in Marrow Cultures from Leukaemic Patients in Relapse and Remission (1974) (21)
- Specificity of interacting populations affecting granulopoiesis in culture. (1974) (21)
- Clinical and economic analysis of allogeneic peripheral blood progenitor cell transplants: a Canadian perspective (1998) (21)
- Favorable overall survival with fully myeloablative allogeneic stem cell transplantation for follicular lymphoma. (2008) (21)
- Pluripotent hemopoietic progenitors (CFU-GEMM) in chronic myelogenous leukemia. (1983) (20)
- Management of allogeneic bone marrow transplant recipients at risk for cytomegalovirus disease using a surveillance bronchoscopy and prolonged pre-emptive ganciclovir therapy. (1999) (20)
- Benefit of allogeneic transplantation in patients age ≥ 60 years with acute myeloid leukemia is limited to those in first complete remission at time of transplant. (2014) (20)
- Treatment of elderly patients with acute lymphoblastic leukemia--evidence for a benefit of imatinib in BCR-ABL positive patients. (2005) (20)
- Purification of terminal deoxynucleotidyltransferase by oligonucleotide affinity chromatography. (1978) (20)
- Prevention of acute pulmonary edema after bone marrow transplantation. (1987) (20)
- Merocyanine 540-sensitized photoinactivation of high-grade non-Hodgkin's lymphoma cells: potential application in autologous BMT. (1993) (20)
- Incidence and Risk Factors for Nontuberculous Mycobacterial Infection after Allogeneic Hematopoietic Cell Transplantation. (2018) (20)
- Pneumatosis intestinalis with free air mimicking intestinal perforation in a bone marrow transplant patient. (1994) (19)
- Therapy-related leukemia and myelodysplasia in small-cell lung cancer. Report of a case and results of morphologic, cytogenetic, and bone marrow culture studies in long-term survivors. (1986) (19)
- Outcomes of patients with therapy-related AML/myelodysplastic syndrome (t-AML/MDS) following hematopoietic cell transplantation (2015) (19)
- Risk stratification of organ-specific GVHD can be improved by single-nucleotide polymorphism-based risk models (2014) (19)
- Flexible association of hemopoietic differentiation programs in multilineage colonies (1984) (19)
- Pregnancy after BMT: three case reports. (1993) (19)
- A comparison of long-term outcomes of donor lymphocyte infusions and tyrosine kinase inhibitors in patients with relapsed CML after allogeneic hematopoietic cell transplantation. (2014) (18)
- A human lymphoma cell line with multiple immunoglobulin rearrangements. (1992) (18)
- Early lymphocyte recovery at 28 d post‐transplant is predictive of reduced risk of relapse in patients with acute myeloid leukemia transplanted with peripheral blood stem cell grafts (2014) (18)
- Mobilization of Leukemic Cells Using Plerixafor as Part of a Myeloablative Preparative Regimen for Patients with Acute Myelogenous Leukemia Undergoing Allografting: Assessment of Safety and Tolerability. (2019) (17)
- Human stem cells in culture. (1984) (17)
- Constitutive production of the interleukins IL-5 and IL-6 by the lymphoma cell line OCI-Ly 17 derived from a patient with malignant lymphoma and hypereosinophilia. (1992) (17)
- The clinical utility of CMV surveillance cultures and antigenemia following bone marrow transplantation (1999) (17)
- Radiosensitivity of human clonogenic myeloma cells and normal bone marrow precursors: effect of different dose rates and fractionation. (1994) (17)
- The combined use of cytosine arabinoside, cyclophosphamide, and total body irradiation as preparative regimen for bone marrow transplantation in patients with AML and CML. (1985) (17)
- Effects of combined antigrowth factor receptor treatment on in vitro growth of multiple myeloma. (1994) (16)
- Preclinical assessment of human hematopoietic progenitor cell transduction in long-term marrow cultures. (1996) (16)
- Empiric therapy for infections in granulocytopenic cancer patients: continuous infusion of amikacin plus cephalothin. (1979) (16)
- Human hematopoietic progenitor in bone marrow and peripheral blood (1998) (16)
- Acute leukemia of donor origin arising after stem cell transplantation for acute promyelocytic leukemia. (2004) (16)
- Mycophenolate‐based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative‐related donor stem cell transplantation (2015) (15)
- Interleukin-6 levels in the plasma of patients with lymphoma. (1992) (15)
- Influence of One Human Leukocyte Antigen Mismatch on Outcome of Allogeneic Bone Marrow Transplantation from Related Donors (2003) (15)
- Allogeneic peripheral blood stem cell transplantation significantly increases risk of chronic graft-versus-host disease of lung compared with bone marrow transplantation. (2012) (15)
- Nocardial endophthalmitis and subretinal abscess: CT and MR imaging features with pathologic correlation: a case report. (2005) (15)
- Risk model incorporating donor IL6 and IFNG genotype and gastrointestinal GVHD can discriminate patients at high risk of steroid refractory acute GVHD (2015) (14)
- Determination of IL6, IL1, and IL4 in the plasma of patients with multiple myeloma. (1994) (14)
- G6PD isoenzyme analysis of myeloid and lymphoid cells in human multilineage colonies (1984) (14)
- Corticosteroid induced tumor lysis syndrome in acute lymphoblastic leukemia (1992) (14)
- Mechanisms and Treatment of Graft Failure (2009) (14)
- Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL). (2005) (14)
- Myeloablative versus Reduced-Intensity Conditioning in Patients with Myeloid Malignancies: A Propensity Score-Matched Analysis. (2016) (14)
- Modified EBMT Pretransplant Risk Score Can Identify Favorable-risk Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for AML, Not Identified by the HCT-CI Score. (2015) (13)
- Clinico-Biological Features and Prognostic Significance of PML/RARα Isoforms in Adult Patients with Acute Promyelocytic Leukemia Treated with All Trans Retinoic Acid (ATRA) and Chemotherapy (2004) (13)
- Outcome following second allogeneic hematopoietic cell transplantation: A single‐center experience (2018) (13)
- Extramedullary disease at diagnosis of AML does not influence outcome of patients undergoing allogeneic hematopoietic cell transplant in CR1 (2017) (13)
- A Phase I Trial of Two Sequence-Specific Schedules of Decitabine and Vorinostat in Patients with Acute Myeloid Leukemia (AML). (2007) (13)
- Nontargeted stable integration of recombinant adeno-associated virus into human leukemia and lymphoma cell lines as evaluated by fluorescence in situ hybridization. (1999) (13)
- Incidence, risk factors, and long-term outcomes of sclerotic graft-versus-host disease after allogeneic hematopoietic cell transplantation. (2014) (13)
- Outcomes of hematopoietic cell transplantation in adult patients with acquired aplastic anemia using intermediate-dose alemtuzumab-based conditioning. (2014) (13)
- Assessment and characterization of hemopoietic stem cells (1995) (12)
- Intrathecal vancomycin in the treatment of Ommaya reservoir infection by Staphylococcus epidermidis. (1991) (12)
- Acute intestinal graft-versus-host disease in a syngeneic bone marrow transplant recipient. (1998) (12)
- Minimal residual disease in bone marrow transplant recipients with chronic myeloid leukemia. (1994) (12)
- Flow cytometric assessment of autologous γδ T cells in patients with acute myeloid leukemia: Potential effector cells for immunotherapy? (2006) (11)
- The Stem Cell Club: a model for unrelated stem cell donor recruitment (2017) (11)
- Comparative testing of peripheral blood and bone marrow for BCR-ABL transcripts in patients post allogeneic bone marrow transplantation and during interferon treatment for chronic myeloid leukemia. (1999) (11)
- Marrow transplantation for severe aplastic anemia with significant renal impairment (2007) (11)
- Chronic lymphocytic leukemia in the course of chronic myelocytic leukemia: evidence of independent clonal origin as shown by interphase fluorescence in situ hybridization and fluorescence-activated cell sorting. (2004) (11)
- Differences in cell cycle kinetics of candidate engrafting cells in human bone marrow and mobilized peripheral blood. (2001) (11)
- Improved prognostic stratification power of CIBMTR risk score with the addition of absolute lymphocyte and eosinophil counts at the onset of chronic GVHD (2017) (11)
- Flow cytometric assessment of autologous gammadelta T cells in patients with acute myeloid leukemia: potential effector cells for immunotherapy? (2006) (11)
- A novel diquinolonium displays preclinical anti-cancer activity and induces caspase-independent cell death (2008) (10)
- Long-term outcome of allogeneic transplants in acute myeloid leukemia (2002) (10)
- Quality of life trajectories during the first year following hematopoietic cell transplantation: an inception cohort study (2018) (10)
- A new syndrome of familial aplastic anemia and chronic liver disease. (1997) (10)
- Serum IgA in recurrent croup. (1983) (10)
- Evidence of graft-versus-Waldenstrom's macroglobulinaemia effect after allogeneic stem cell transplantation: a single centre experience (2007) (10)
- Allogeneic stem cell transplantation for mantle cell lymphoma--does it deserve a better look? (2005) (9)
- Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic haematopoietic stem cell transplant (2018) (9)
- Pleural effusions in patients treated with dasatinib: Results from two institutions, risk factors and management (2007) (9)
- Targeted recruitment of optimal donors for unrelated hematopoietic cell transplantation: The Stem Cell Club process. (2020) (9)
- High-dose cytosine arabinoside remission induction for acute myelogenous leukemia: comparison of two regimens of remission maintenance. (1992) (9)
- Intracellular cytokine analysis of interferon-gamma in T cells of patients with chronic myeloid leukemia. (2002) (9)
- Stimulatory activity for human pluripotent hemopoietic progenitors produced by a human T-lymphocyte cell line. (1981) (9)
- How good is allogeneic transplantation for high-risk patients with AML? (2006) (8)
- The heritable nature of clonal characteristics in acute myeloblastic leukemia. (1981) (8)
- Impact of comorbidities constituting the HCT-CI score on the outcome of patients undergoing allogeneic HCT for AML. (2017) (8)
- Assessment of the downstream portion of the mitochondrial pathway of caspase activation in patients with acute myeloid leukemia (2005) (8)
- Human hemopoietic progenitors and their signals. (1991) (8)
- Bone marrow transplantation in patients with acute leukaemia. (1972) (8)
- Impact of comorbidities constituting the hematopoietic cell transplant (HCT)‐comorbidity index on the outcome of patients undergoing allogeneic HCT for acute myeloid leukemia (2018) (8)
- Management of Hyperleukocytosis in Acute Myelogenous Leukemia Using Hydroxyurea Rather Than Leukopheresis. (2006) (8)
- Concise manual of hematology and oncology (2008) (8)
- Limited benefit of pentostatin salvage therapy for steroid‐refractory grade III‐IV acute graft‐versus‐host disease (2013) (8)
- Regulation of interleukin‐6 expression in the lymphoma cell line OCI‐LY3 (1991) (8)
- Long-term sequelae after recovery from cytomegalovirus pneumonia in allogeneic bone marrow transplant recipients. (1992) (7)
- Growth and detection of human bone marrow B-lineage colonies. (1990) (7)
- Growth of human lymphoma cells in SCID mice. (1992) (7)
- Characteristics of erythroid colonies formed by bovine marrow progenitor cells in methyl cellulose cultures. (1982) (6)
- Bone Marrow Transplantation for Chronic Myelogenous Leukemia in Chronic Phase (2020) (6)
- Long-term outcomes in adult patients below the age of 55 years with acute lymphoblastic leukemia treated with chemotherapy or allogeneic BM transplant in first CR (2010) (6)
- Fludarabine and busulfan plus low-dose TBI as reduced intensity conditioning in older patients undergoing allogeneic hematopoietic cell transplant for myeloid malignancies (2018) (6)
- Treatment of Adult Acute Lymphoblastic Leukemia (ALL) with a Modified DFCI Pediatric Regimen - The Princess Margaret Experience. (2006) (6)
- Immunosuppression as initial treatment for gold induced aplastic anemia. (1987) (6)
- Chronic myeloid leukemia in a woman with Still's disease treated with 198Au synoviorthesis. (1991) (6)
- Examining the safety and efficacy of a chemotherapy dosing method in Allogeneic Stem Cell Transplant patients of extreme body size (2009) (6)
- Restriction fragment length polymorphism analysis of hematopoietic cells following successful treatment of relapsed acute lymphoblastic leukemia following bone marrow transplantation. (1989) (5)
- Cell culture assessment of hematopoietic progenitors in bone marrow transplantation. (1993) (5)
- Bronchial mucosal infiltration and unilateral lung collapse: an unusual complication of multiple myeloma. (1988) (5)
- Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study (2016) (5)
- Development of a computerized data collection and record system (1986) (5)
- Predictors of the trajectory of cognitive functioning in the first 6 months after allogeneic hematopoietic stem cell transplantation (2019) (5)
- Long-term follow-up of allogeneic bone marrow transplantation for patients with chronic phase chronic myeloid leukemia prepared with a regimen consisting of cyclophosphamide, cytarabine and single-dose total body irradiation conditioning (2007) (5)
- Segregation of precursors with high proliferative potential from their differentiated progeny in a myeloma cell line (1988) (5)
- Long-term persistence of IL-2-unresponsive allogeneic T cells in sublethally irradiated SCID mice. (1999) (5)
- Magna-field irradiation: work in progress in bone marrow transplantation at The Princess Margaret Hospital, Toronto. (1983) (5)
- Human albumin eye drops as a therapeutic option for the management of keratoconjunctivitis sicca secondary to chronic graft-versus-host disease after stem-cell allografting. (2015) (5)
- Distinctive clinical characteristics and favorable outcomes in patients with large granular lymphocytosis after allo‐HCT: 12‐year follow‐up data (2017) (5)
- Cyclosporine a in the treatment of acute graft‐versus‐host disease (1986) (5)
- Long-Term Incidence of Secondary Malignancies after Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience. (2017) (5)
- Correction of recurrent angioedema related to C1 esterase inhibitor deficiency as a secondary event following nonmyeloablative allogeneic stem cell transplantation in a patient with myelofibrosis (2005) (4)
- Assessment of human pluripotent hemopoietic progenitors and leukemic blast-forming cells in culture. (1981) (4)
- A unique case of tuberculosis dissemination presenting as cutaneous lesions in a post allogeneic stem cell transplant patient (2016) (4)
- [Experimental bone marrow fibrosis in rats following sublethal whole-body x-ray irradiation and bone marrow transfusions as a model of human myelofibrosis]. (1968) (4)
- Influence of FLT3‐ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML (2019) (4)
- G6PD isoenzyme analysis of myeloid and lymphoid cells in human multilineage colonies. (1984) (4)
- Do allogeneic bone marrow transplant candidates match coping to controllability of pre-treatment stressors? (2008) (4)
- Bone marrow transplantation in hemopoietic malignancies. (1991) (4)
- The maintenance of busulphan-induced remissions in chronic granulocytic leukaemia with recombinant interferon alpha-2b. (1990) (4)
- Stimulatory activity of PHA-LCM for normal human hemopoietic progenitors and leukemic blast cell precursors: separation by isoelectric focusing. (1981) (3)
- Interferon alfa-2b in the treatment of chronic granulocytic leukemia (2004) (3)
- Characterization of reticulo‐fibroblastoid colonies (CFU‐rf) derived from bone marrow and long‐term culture adherent layers (1986) (3)
- Cavernous sinus thrombosis presenting with diplopia in an allogeneic bone marrow transplant recipient (2004) (3)
- Small-Molecule XIAP Inhibitors Derepress Downstream Effector Caspases and Induce Apoptosis of Leukemia Cell Lines and Patient Samples. (2004) (3)
- Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Gene Polymorphisms To Predict Response and Resistance to Imatinib Mesylate Therapy in Chronic Myeloid Leukemia. (2007) (3)
- The Modified Pre-Transplant EBMT Risk Score Is Superior To The HCT-CI Score In Predicting Overall Survival and Non-Relapse Mortality After Allogeneic Hematopoietic Cell Transplantation In Patients With Acute Myeloid Leukemia (2013) (3)
- Precursor lymphoblastic lymphoma reoccurring as a donor-derived neoplasm: a case report and review of the literature. (2008) (3)
- Fetal hemoglobin analysis of erythroid bursts in patients with chronic myelogenous leukemia (CML). (1983) (3)
- Formation of lymphocyte colonies under serum‐free culture conditions in normal individuals and patients with chronic lymphocytic leukemia (1987) (3)
- Stem cells: the challenge and opportunities (2008) (3)
- [Chronic intermittent duodenal obstruction in childhood]. (1990) (3)
- Leucocytokinetic studies during viral hepatitis (2004) (3)
- Efficacy of Cidofovir in Treatment of BK Virus Induced Hemorrhagic Cystitis in Post Allogeneic Hematopoietic Cell Transplant Recipients (2017) (3)
- Clinical Characteristics, Risk Factors and Outcomes of CMV Disease after Allogeneic Stem Cell Transplantation (2014) (2)
- Prolonged Disease-Free Survival in an Adult Presenting with Burkitt-Type Acute Lymphoblastic Leukaemia and CNS Disease (1992) (2)
- Risk Factors and Management of Patients with Pulmonary Abnormalities and Philadelphia Chromosome–Positive Leukemia After Treatment with Dasatinib: Results from Two Institutions (2008) (2)
- Secondary cancer after syngeneic bone marrow transplant. (1995) (2)
- Progressive Multifocal Leukoencephalopathy due to John Cunningham (JC) virus following Allogeneic Haematopoietic Cell Transplantation (2017) (2)
- Incidence, Risk Factors for Early Hepatotoxicity and Its Impact on Survival in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Cell Transplantation (2011) (2)
- Optimization Of Alemtuzumab Dose For Graft-Versus-Host Disease Prophylaxis For Reduced Intensity Transplantation From Unrelated Donors For Patients With Hematologic Malignancies (2009) (2)
- Safety of two-hour intermittent intravenous infusions of tacrolimus in the allogeneic hematopoietic stem cell transplantation unit (2018) (2)
- Three decades of allogeneic bone marrow transplants at the Princess Margaret Hospital. (1999) (2)
- Extended duration between harvest and re-infusion of human bone marrow stored at room temperature (1997) (2)
- Acute Leukemia during Pregnancy: The Toronto Leukemia Study Group Experience with Long-term Follow-up of Children Exposed in Utero to Chemotherapeutic Agents (1988) (2)
- BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKAEMIA (1985) (2)
- Incidence and Risk Factors for Nontuberculous Mycobacteria Infection after Allogeneic Hematopoietic Cell Transplantation (2015) (2)
- A short tale of blood, kidney and brain: BK virus encephalitis in an allogeneic stem cell transplant recipient (2017) (2)
- 350: Clinical efficacy of long-term low dose acyclovir for VZV infection prophylaxis after allogeneic peripheral blood stem cell transplantation (2007) (2)
- Incidence of Secondary Malignancies Following Allogeneic Hematopoietic Cell Transplantation: A Single Center Experience (2014) (2)
- Unrelated bone marrow transplantation in Canada, the national experience. (1991) (2)
- The heterogeneity of cell culture findings in patients with acute myeloblastic leukemia. (1973) (2)
- First Ready, First to Go: Ethical Priority-Setting of Allogeneic Stem Cell Transplant at a Major Cancer Centre (2020) (2)
- 148Immunoablative therapy with purified autologous stem cells rescue for the treatment of poor prognosis MS (2003) (2)
- The role of second bone marrow transplant using a different donor for relapsed leukemia or graft failure (1997) (2)
- Osteomyelofibrose in Ratten nach letaler Ganzkörperbestrahlung und Tranfusion allogener Knochenmarkzellen. EUR 4043. = Osteomyelofibrosis in rats after lethal wholebody irradiation and transfusion of allogenic bone marrow cells. EUR 4043. (1968) (1)
- Low hemoglobin level pre-BMT is associated with higher RBC transfusion rates and poorer survival in allogeneic BMT recipients (2005) (1)
- A Longitudinal Comparison Of Quality Of Life (QOL) In Patients With Myeloid Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation (ALLOHCT) Using Myeloablative (MY) Or Reduced Intensity Conditioning (RIC) (2010) (1)
- Bronchiolitis in allogeneic bone marrow transplant recipients (1986) (1)
- The Risk Factors for IgG Hypogammaglobulinemia after Allogeneic Hematopoietic Stem Cell Transplantation and Its Impact on Transplant Outcomes (2014) (1)
- Analysis of Impact of Comorbidities Constituting the HCT-CI Score on the Outcome of Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia (2015) (1)
- 72 Allogeneic bone marrow transplantation for myelofibrosis due to agnogenic myeloid metaplasia (AMM) and essential thrombocytosis (ET): Experience of two bone marrow transplant centers (2003) (1)
- Current status of blood and marrow transplantation for patients with AML (2008) (1)
- A Pilot Trial of Two Dose Levels of Rabbit Antithymocyte Globulin, (rATG), Thymoglobulin, as Part of a Myeloablative-Conditioning for a HLA Identical Matched Related Donor Stem Cell Transplant (SCT) with Cyclosporine (CsA) as Graft Versus Host Disease (GvHD) Prophylaxis. (2006) (1)
- Hemopoietic precursors in human bone marrow transplantation. (1986) (1)
- The effect of local breast radiotherapy on circulating CD34(+) cells. (2011) (1)
- Predictors of the Trajectory of Neurocognitive Functioning in the First Six Months after Allogeneic Hematopoietic Stem Cell Transplantation (2015) (1)
- The Benefit of Allogeneic Hematopoietic Cell Transplantation in Older Patients with Acute Myeloid Leukemia Is Restricted to Those in First Complete Remission At the Time of Transplantation. (2012) (1)
- Current Clinical Practice: Acute Myeloblastic Leukemia: Management with High-Dose Cytosine Arabinoside, Daunorubicin and Marrow Transplantation (2000) (1)
- Identification of megakaryocytes in human bone marrow culture: nonspecificity of acid phosphatase. (1980) (1)
- [Studies of calcium phosphate metabolism in a case of McCune-Albright syndrome with phosphate diabetes (author's transl)]. (1974) (1)
- Combination of the Centre for International Blood and Marrow Transplant Registry Risk Score and the Global Severity Score Enhances Prognostic Risk Stratification in Patients Receiving Frontline Therapy for Chronic Graft-versus-Host Disease. (2019) (1)
- [Vertebrobasilar insufficiency of prenatal origin: a case report]. (1986) (1)
- Therapeutic efficacy of azathioprine in addition to prednisone-based regimens as first-line chronic graft-versus-host disease treatment (2017) (1)
- Erythroid burst formation in normal murine bone marrow and friend virus induced erythroleukemia: influence of igg preparations from a patient with pure red cell aplasia (prca). Abstr. (1980) (1)
- Human megakaryocytopoiesis in cell culture. (1985) (1)
- Accumulation of Sestamibi in Lymphoma Cell Lines In Vitro (2000) (1)
- The role of CFU-GEMM in human hemopoiesis (1986) (1)
- Systematic Review of Cases of Transfusion Associated Graft-Versus-Host-Disease (TA-GVHD): Analysis of Patient Characteristics and Outcomes (2014) (1)
- Molecular relapse after allogeneic hematopoietic cell transplant for chronic myeloid leukemia: some long-term survivors appear to tolerate even lack of major molecular response (2014) (1)
- In vitro examination of human megakaryocyte precursors. (1986) (1)
- Differentiation profiles of normal blast cell colonies derived from mononucleated cells, T cell depleted nonadherent cells and CD33-negative, CD34-positive normal human bone marrow cells. (1992) (1)
- Human leukemia: cell culture. (1986) (1)
- A cross-Canada survey of cytomegalovirus prevention and treatment practices in bone marrow transplant recipients. (1999) (1)
- A Critically Unnoticed Condition, Secondary Hemophagocytosis Post Allogeneic Bone Marrow Transplant in Adults (2017) (1)
- Thrombotic Events in Adults with Acute Lymphoblastic Leukemia. (2004) (1)
- Post Transplant Cyclophosphamide (PTCy) with Anti-Thymocyte Globulin (ATG) Effectively Reduces the Severe (Grade III-IV) Acute Graft-Versus-Host Disease (GVHD) When Compared to ATG Alone in Matched Unrelated Donor (MUD) Allogeneic Hematopoietic Cell Transplants (2016) (1)
- Transient myeloproliferative disorder with a CD7+ and CD56+ myeloid/natural killer cell precursor phenotype in a newborn. (2002) (1)
- Outcome Following Second Allogeneic Hematopoietic Cell Transplantation: A Single Centre Experience (2016) (1)
- [Congenital Agranulocytosis (author's transl)]. (1975) (0)
- Refined Hepatic Grading System Improves Risk Stratification of Long-Term Outcomes in the Patients Developing Chronic Gvhd (2016) (0)
- Functional Assessment of the Mitochondrial Pathway of Caspase Activation in Patients with Acute Myeloid Leukemia (AML). (2004) (0)
- Post Transplant Cyclophosphamide (PTCy) with Anti-Thymocyte Globulin (ATG) Effectively Reduces the Severe (Grade III-IV) Acute Graft-Versus-Host Disease (GVHD) When Compared to ATG Alone in Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplants (2017) (0)
- Multiple CMV Reactivations Are Associated with Lower Risk of Relapse Following Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation (2014) (0)
- Validation of Favourable Impact of Large Granular Lymphocytosis after Allogeneic Hematopoietic Cell Transplantation (2014) (0)
- Glucose 6 phosphate dehydrogenase analysis of myeloid and lymphoid cells in multi lineage colonies (1983) (0)
- OSTEOMYELOFIBROSIS IN RATS AFTER LETHAL WHOLE-BODY IRRADIATION AND TRANSFUSION OF ALLOGENIC BONE MARROW CELLS. (1968) (0)
- Frequency of Human Trichinosis. (0)
- Lymphocyte Recovery At Day 28 Post-Transplant Is Predictive Of Relapse In Patients With Acute Myeloid Leukemia Transplanted With Peripheral Blood Stem Cell Grafts (2013) (0)
- Early Recovery Of Absolute Lymphocyte Counts ≥ 0.2x109/L At Day 21 Can Predict Reduced Risk Of Relapse In Acute Lymphoblastic Leukemia Following Allogeneic Stem Cell Transplantation (2013) (0)
- Long-term growth of bcr-abl positive progenitor cells from CNL patients in suspension culture. (1995) (0)
- Clonogenic hematopoietic progenitors and endogenous cytokine production in allogeneic bone marrow transplantation. (1993) (0)
- 240Bone marrow aspirates as part of routine donor assessment for allogeneic blood and marrow transplantation can reveal occult hematological malignancies in asymptomatic individuals (2003) (0)
- Negative Impact of Pre-Transplant Anemia on Long-Term Outcome after Allogeneic Hematopoietic Stem Cell Transplantation. (2004) (0)
- Factors Influencing Varicella-Zoster Virus (VZV) Infection after Allogeneic Peripheral Blood Stem Cell Transplantation: Low-Dose Acyclovir Prophylaxis and Pre-Transplant Diagnosis of Lymphoproliferative Disorders. (2006) (0)
- Effective Strategy to Prevent Acute Graft-Versus-Host Disease in Unrelated Donor Allogeneic Hematopoietic Cell Transplants By Using a Combination of Anti-Thymocyte Globulin (ATG), Post-Transplant Cyclophosphamide and Cyclosporine (2016) (0)
- 241: Neurological complications in the recipients of allogeneic hematopoietic cell transplant (2007) (0)
- Comparison of the Impact of Pre-Transplant Co-Morbidity Scores on Allogeneic Hematopoietic Stem Cell Transplant Outcomes (2018) (0)
- [Thrombasthenia in a newborn (author's transl)]. (1979) (0)
- Favourable Overall Survival with Myeloablative Allogeneic Stem Cell Transplantation for Follicular Lymphoma. (2006) (0)
- Mycophenolate Compared to Methotrexate As Part of Cyclosporine Based-GVHD Prophylaxis Does Not Affect Transplant Outcomes, Reduces Organ Specific Acute And Chronic GVHD, but Increases The Risk of CMV Viremia In Matched Related Donor Peripheral Blood Stem Cell Transplantation (2013) (0)
- Bone marrow transplants for patients with acute leukemia and myelodysplastic syndrome using unrelated donors. (1991) (0)
- Development of an adoptive cell therapy protocol with tumor-infiltrating lymphocytes and intermediate-dose interleukin-2 therapy (2013) (0)
- Impact of Conditioning on the Outcome of Allografting in Myelofibrosis with Myeloid Metaplasia: Better Survival with Reduced Intensity Approach in Patients ≥50 Years. (2007) (0)
- [Bone marrow failure with plasmocytosis in a diabetic child (author's transl)]. (1980) (0)
- Prognostic Power of Chronic Gvhd Risk Score Model by Ibmtr Can Be Improved with Addition of Absolute Lymphocyte Counts and Eosinophil Counts At the Onset of Chronic Gvhd (2012) (0)
- [Epidemic hepatitis and bone-marrow depression (author's transl)]. (1974) (0)
- Rapid decline of clonogenic hemopoietic progenitors in semisolid cultures of bone marrow samples derived from patients with chronic myeloid leukemia. (1989) (0)
- Two-Digit Resolution Typing Of Class-I Human Leukocyte Antigen (HLA) Does Not Compromise Outcomes In Adults Undergoing Matched Unrelated Allogeneic Bone Marrow Transplantation (2010) (0)
- Comprehensive Analysis of Systemic Immunosuppression (SIS) Duration after Allogeneic Hematopoietic Stem Cell Transplant: Risk Score Model Provides Stratification of Patients According to Probability of SIS Discontinuation (2018) (0)
- 107: Evidence of successful allogeneic transplantaiton using cryopreserved peripheral blood stem cells from healthy donors (2007) (0)
- Product Attributes and Donor Factors in Reported Cases of Transfusion-Associated Graft Versus Host Disease: A Systematic Review (2014) (0)
- A Risk Score to Predict CMV Viremia within the First 100 Days after Allogeneic Stem Cell Transplantation Based on Pre-Transplant Parameters (2014) (0)
- [Localization of segmentally bound pneumonia in childhood]. (1958) (0)
- The impact of pre-transplant anemia on long-term survival following allogeneic bone marrow transplantation (2004) (0)
- Impact of Myeloablative Versus Reduced Intensity Conditioning Regimens on Early Lymphocyte Recovery and Its Impact on Transplant Outcomes after Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients with Hematologic Malignancies. (2007) (0)
- multilineage colonies G6PD isoenzyme analysis of myeloid and lymphoid cells in human (2011) (0)
- [Treatment of Wilms' tumor (author's transl)]. (2008) (0)
- Autologous Gamma-Delta T (GD-T) Cells in Acute Myeloid Leukemia (AML): Potential Immune Effector Cells for Minimal Disease?. (2004) (0)
- Comprehensive Analysis of Pre-Transplant Pulmonary Function Test Parameters Including FEV1, FVC, DLco, FEF50%/75%, Frc, RV and TLC As Prognostic Factors for Long-Term Outcomes after Allogeneic Transplantation (2016) (0)
- Normal and Leukemic Human Marrow Cells Interacting Cell Populations Affecting Granulopoietic Colony Formation by (2011) (0)
- A Comparison Of Long-Term Outcomes Of Donor Lymphocyte Infusions and Tyrosine Kinase Inhibitors In CML Patients Relapsed After Allogeneic Hemopoietic Stem Cell Transplantation (2013) (0)
- Risk Factor Analysis for the Development of Large Granular Lymphocytosis after Allogeneic Hematopoietic Cell Transplantation: Randomized Stratification and Propensity Score Analysis (2015) (0)
- Extramedullary Disease at Diagnosis of Acute Myeloid Leukemia Does Not Influence Outcome of Patients Undergoing Allogeneic Hematopoietic Cell Transplant in First Complete Remission (2015) (0)
- HCT-CI Has Prognostic Value in Acute, but Not Chronic Gvhd Specific Survival (2014) (0)
- MYELOID NEOPLASIA Treatment outcomes following leukemic transformation in Philadelphia-negative myeloproliferative neoplasms (2013) (0)
- Micafungin Followed by Posaconazole is Effective as Primary Antifungal Prophylaxis in First Three Months After Unrelated Donor Transplantation (2013) (0)
- [Current stage of leukemia treatment in children]. (1983) (0)
- The Risk Of BK Virus Haemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation Is Increased With Myeloablative Conditioning, CMV Viremia and Acute Gvhd (2013) (0)
- Incidence and Risk Factors for Vzv Infection after Allogeneic Hematopoietic Cell Transplantation in 1,045 Patients: Younger Age Less Than or Equal to 45, Occurrence of Cgvhd By NIH Consensus Criteria, and No T-Cell Depletion (2015) (0)
- High Post-Transplant Ferritin Level Associates with Adverse Survival and Higher Mortality Rate following Allogeneic Hematopoietic Stem Cell Transplant, whereas Pre-Transplant Ferritin Level Does Not (2018) (0)
- Impact of the Intensity of Conditioning Therapy On the Outcomes of Patients Aged 40 to 60 Years with Acute Myeloid Leukemia/Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation. (2009) (0)
- Once daily intravenous busulfan as part of a busulfan/cyclophosphamide conditioning regimen for allogeneic hematopoietic stem cell transplantation (2004) (0)
- Allogeneic Stem Cell Transplantation Is Associated with Long Term Disease Control in Chemo Sensitive Follicular Lymphoma Patients (2011) (0)
- Expansion of Large Granular Lymphocytes Following Allogeneic Stem Cell Transplantation: Its Association with Graft-Versus-Host Disease and Graft-Versus-Leukemia Effect. (2009) (0)
- Fludarabine/Busulfan Plus Low Dose TBI As Reduced Intensity Conditioning in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Myeloid Malignancies (2016) (0)
- [Chemical pneumonitis following lymphangiography in childhood (author's transl)]. (1974) (0)
- Early Recovery of Absolute Lymphocyte Count (ALC) Is a Predictor of Long-Term Outcome Following Related Allogeneic Peripheral Blood Stem Cell Transplantation in Adults with AML/MDS. (2007) (0)
- Conditioning regimen Busulfan and cyclophosphamide as a preparative regimen for allogeneic blood and marrow transplantation in patients with non-Hodgkin's lymphoma (2003) (0)
- Growth factors in bone marrow transplant recipients. (1988) (0)
- Donor Type, Chronic Gvhd Subtype , and the Severity of Chronic Gvhd at the Time of Initiation of Chronic Gvhd Treatment Affect Failure-Free Survival in the Patients with Chronic Gvhd (2015) (0)
- Lymphoma cell culture under serum-free conditions (1993) (0)
- The NIH Chronic Gvhd Global Score and the CIBMTR Risk Score Correlate Well with Failure Free Survival Following Frontline Systemic Corticosteroid Therapy for Chronic Gvhd (2014) (0)
- Limited Benefit of Pentostatin Salvage Therapy for Steroid Refractory Acute Graft Versus Host Disease (2012) (0)
- Attempts to Optimizing the Outcomes of Allogeneic Hematopoietic Cell Transplantation in Older Patients (≥60 Years) With Acute Myeloid Leukemia and Myelodysplastic Syndrome (2011) (0)
- Late Onset Eosinophilia (beyond Day 100), Rather Than Early Onset Eosinophilia, Has a Significant Prognostic Impact on Transplant Outcomes after Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT). (2007) (0)
- [Prostacyclin in the treatment of persistent fetal circulation syndrome]. (1992) (0)
- Long-Term Follow-Up of Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia. (2006) (0)
- e ffect of Noncompetitive Proteasome i nhibition on Bortezomib r esistance (2010) (0)
- CMV Reactivations and Their Impact On Outcomes in Patients After Hematopoietic Cell Transplantation (2012) (0)
- Continuous Infusion of Amikacin Plus Cephalothin (2016) (0)
- Evaluation of the Disease Risk Index on Outcomes Following Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes (2014) (0)
- A Prospective Comparison Of Outcomes And Resource Utilization In Patients With Myeloid Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation (AlloHCT) Using Myeloablative Or Reduced Intensity Conditioning (2010) (0)
- 141An intent to treat analysis of chemotherapy versus allogeneic bone marrow transplant in first complete remission (CRI) for adult patients below the age 55 years with acute lymphoblastic leukemia (ALL): Results from Princess Margaret Hospital (2003) (0)
- Outcomes of Allogeneic Hematopoietic Cell Transplantation In Aplastic Anemia Using Intermediate Dose Alemtuzumab Based-Conditioning (2013) (0)
- Long Term Outcomes Of Allogeneic Stem Cell Transplantation For Chronic Lymphocytic Leukemia (2010) (0)
- Acute Myeloblastic Leukemia: Management with High-Dose Cytosine Arabinoside, Daunorubicin and Marrow Transplantation; Malignancy; Current Clinical Practice. (2000) (0)
- Outcome of Patients with Secondary Leukemias Managed with Different Treatment Strategies at a Single Center. (2005) (0)
- Comprar Concise Manual of Hematology and Oncology | Andreeff, Michael | 9783540732761 | Springer (2008) (0)
- Myeloid and lymphoid repertoire of human pluripotent hemopoietic progenitors (CFU-GEMM). (1984) (0)
- Development and Validation of a Prognostic Score Involving Disease Status, Patient Age and Donor Type for Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia (2014) (0)
- Acyclovir and Cytomegalovirus Immunoglobulins as Prophylaxis for Cytomegalovirus Infections in Allogeneic Bone Marrow Transplant Recipients (1997) (0)
- 148: Salvage and disease control of aggressive histology non-Hodgkin’s lymphoma by allogeneic stem cell transplantation (2007) (0)
- Patients With Neutropenia Analysis of Interacting Cell Populations in Cultures of Marrow From (2011) (0)
- Risk Factors For Chronic Eye and Mouth GVHD In Unrelated Hematopoietic Cell Transplantation: T Cell Depletion Is The Only Risk Factor Identified and Appears To Be Favorable (2013) (0)
- The Risk of Organ Specific Graft-Versus-Host Disease Can Be Predicted by the Multiple Single Nucleotide Polymorphism Based Predictive Models. (2012) (0)
- No Significance of Derivative Chromosome 9 Deletion on the Clearance Kinetics of BCR/ABL Fusion Transcripts, Cytogenetic or Molecular Response, Loss of Response or Treatment Failure to Imatinib Mesylate Therapy for Chronic Myeloid Leukemia. (2007) (0)
- Moderate/Severe Grade of Chronic Graft Versus Host Disease and Younger Age (Less Than 45 Years Old) Are Risk Factors for Avascular Necrosis in Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (2015) (0)
- Clinical Relevance Of Large Granular Lymphocyte Expansion Following Allogeneic Hematopoietic Stem Cell Transplantation With HLA Identical Sibling Donors (2010) (0)
- Evidence of Effect Modification of Graft-Versus-Leukemia Effect of Cytomegalovirus By Alemtuzumab in Myeloid Malignancies Undergoing Unrelated Donor Transplantation (2014) (0)
- Serum Albumin Level < 32 g/l on Day 30 Can Predicts Higher Risk of Non-Relapse Mortality in Acute Lymphoblastic Leukemia Following Allogeneic Stem Cell Transplantation (2014) (0)
- Single Nucleotide Polymorphism (SNP)-Based Predictive Models for Graft-Versus-Host Disease (GVHD) Identify High Risk Patients for Overall and Organ Specific GVHD Following Allogeneic Hematopoietic Stem Cell Transplantation (2011) (0)
- Leukemic Transformation of Philadelphia-Negative Myeloproliferative Neoplasms: Results of a Treatment Algorithm Employing Allogeneic Transplantation Using Related and Unrelated Donors (2012) (0)
- 22 The prevalence and severity of fatigue in long-term survivors of allogeneic stem cell transplantation: A preliminary analysis (2003) (0)
- Allogeneic Stem Cell Transplantation Is Associated with Prolonged Disease Control in Chemosensitive Aggressive Histology Lymphoma Patients When Done Early (2011) (0)
- Propensity Score Matching Analysis Comparing Reduced Intensity Versus Myeloablative Conditioning in AML/MDS Patients Transplanted with Fludarabine-Busulfan-Low Dose Total Body Irradiation Based Regimen (2014) (0)
- Clonal proliferation and long-term culture of malignant lymphoma cells under serum-free culture conditions (1990) (0)
- Independent Validation of Chronic Graft-Versus-Host Disease (GVHD) Grading System Proposed by the NIH Consensus Criteria in Terms of Prognostic Stratification of the Patients Developed Chronic Gvhd (2012) (0)
- Megakaryocyte growth supporting activity in human plasma (1986) (0)
- Risk Model Incorporating Donor IL6 and ifng Genotype and Gut Gvhd Can Discriminate High Risk Patients For Steroid Refractory Acute Gvhd (2013) (0)
- Allogeneic bone marrow transplantation from a related donor undergoing long-term immunosuppressive and cytotoxic therapy. (1994) (0)
- Experimental basis of antileukaemic chemotherapy. (1989) (0)
- Propensity Score Matching Analysis Comparing Azathioprine Plus Prednisone Vs Prednisone Alone Regimens As First-Line Treatment in Chronic Graft-Versus-Host Disease (2015) (0)
- Incidence, Risk Factors and Allogeneic Stem Cell Transplant Outcomes In Chronic Sclerotic Gvhd: T-Cell Depletion Is Preventive and Peripheral Blood Stem Cellis a Risk Factor, But Not HLA-Mismatch With No Adverse Impact On Transplant Outcomes (2013) (0)
- Alemtuzumab As Therapy for Steroid Refractory Acute Gvhd: Promising Efficacy but Higher Rate of Infectious Complications Based on Observational Study (2014) (0)
- [Late sequelae of severe injuries to the viscerocranium: clinical, radiographic and CT findings]. (1989) (0)
- CONCISE COMMUNICATIONS Elevated Serum Cytokines Are Associated with Cytomegalovirus Infection and Disease in Bone Marrow Transplant Recipients (1999) (0)
- Steroid Failure At Day 28 After Acute Graft-Versus-Host Disease Treatment and Long-Term Outcomes Following Allogeneic Transplantation: Adverse Impact On Survival and Non-Relapse Mortality But No Increasing Risk Of Relapse (2013) (0)
- Role of Interleukin-6 in the Proliferation of Human Multiple Myeloma (2003) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Hans A. Messner?
Hans A. Messner is affiliated with the following schools:
